e-learning
resources
London 2016
Sunday, 04.09.2016
What's new in biomarker analysis?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The relationship between blood eosinophils and bacterial load in COPD patients
Umme Kolsum (Manchester, United Kingdom), Umme Kolsum, Vandana Gupta, Gavin Donaldson, Richa Singh, Bethan Barker, Leena George, Adam Webb, Sarah Thurston, Chris Brightling, Jadwiga Wedzicha, Dave Singh
Source:
International Congress 2016 – What's new in biomarker analysis?
Session:
What's new in biomarker analysis?
Session type:
Thematic Poster
Number:
899
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Umme Kolsum (Manchester, United Kingdom), Umme Kolsum, Vandana Gupta, Gavin Donaldson, Richa Singh, Bethan Barker, Leena George, Adam Webb, Sarah Thurston, Chris Brightling, Jadwiga Wedzicha, Dave Singh. The relationship between blood eosinophils and bacterial load in COPD patients. Eur Respir J 2016; 48: Suppl. 60, 899
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD – Results from the TIE-study
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Relationship of blood eosinophil count to exacerbations in COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016
Pharmacodynamic effect of benralizumab on blood basophils and serum biomarkers in adults with COPD with sputum eosinophilia
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
Association between qPCR bacterial load and airway inflammation in COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Can blood eosinophils predict sputum eosinophils in stable COPD?
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Blood eosinophils and outcomes in COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Effect of lower airway bacterial colonisation on time to acute exacerbation in patients with COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Relationship between COPD characteristics and airway bacterial load measured using 16S qPCR
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
Quantitative analysis of potentially pathogenic microbes (PPMs) in the induced sputum of non-smoker COPD (NS-COPD) subjects
Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Year: 2016
Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Bacterial infection in hospitalized patients of acute exacerbation of COPD and their relation to lung function: A prospective study
Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Year: 2016
Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Increased circulating alveolar epithelial microparticles in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Cells biomarkers of bronchial brush-biopsies at COPD exacerbation
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013
Can red blood cell morphology be an indicator for COPD exacerbations?
Source: International Congress 2014 – Markers
Year: 2014
Airway glucose in COPD exacerbations
Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Year: 2016
Role of inflammatory biomarkers in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept